Newsletter
Weather
Community
English home Forum Photo Gallery Features Newsletter Archive   About US Help Site Map
China
World
Opinion
Business
Sci-Edu
Culture/Life
Sports
Photos
 Services
- Newsletter
- Online Community
- China Biz Info
- News Archive
- Feedback
- Voices of Readers
- Weather Forecast
 RSS Feeds
- China 
- Business 
- World 
- Sci-Edu 
- Culture/Life 
- Sports 
- Photos 
- Most Popular 
- FM Briefings 
 Search
 About China
- China at a glance
- China in brief 2004
- Chinese history
- Constitution
- Laws & regulations
- CPC & state organs
- Ethnic minorities
- Selected Works of Deng Xiaoping

Home >> Life
UPDATED: 08:27, December 08, 2005
Thailand to produce its own version of anti-bird flu drug
font size    

Thailand's Government Pharmaceutical Organization (GPO) can successfully produce its own version of anti-bird flu capsules with imported raw materials, according to the Minister of Public Health.

Speaking after a meeting of senior officials on the drug production and establishment of an anti-bird flu vaccine plant, Public Health Minister Pinij Jarusombat said it is good news that the Government Pharmaceutical Organization could make Oseltamivir - -the primary anti-bird flu treatment -- with a quality equivalent to the original drug.

Made of the same ingredients, Oseltamivir manufactured in Thailand is 50 percent cheaper than imported Oseltamivir, the generic name of Tamiflu.

GPO director Mongkol Jivasantikarn said it took one year planning for the GPO to produce Oseltamivir in the form of a capsule costing 70 Baht (about 1.75 US dollars), compared to 120 Baht (about 3 US dollars) for a capsule of imported Oseltamivir.

Mongkol said the GPO has a capacity to produce 400,000 capsules of the medicine a day. In case of emergency, it can increase the production to 5 million capsules in a short period.

Anti-bird flu capsules made by the GPO can dissolve easily. Its efficiency in dissolving is as high as 99 percent compared with the original drug, he said.

The Department of Medical Sciences will conduct a bioequivalence study of the newly produced drug in the next four months.

Source: Xinhua


Comments on the story Comment on the story Recommend to friends Tell a friend Print friendly Version Print friendly format Save to disk Save this


   Recommendation
- Text Version
- RSS Feeds
- China Forum
- Newsletter
- People's Comment
- Most Popular
 Related News

Manufacturers, Exporters, Wholesalers - Global trade starts here.
Copyright by People's Daily Online, all rights reserved